Regeneron Pharmaceuticals, Inc. (LON:0R2M)
London flag London · Delayed Price · Currency is GBP · Price in USD
605.14
+5.74 (0.96%)
At close: Oct 3, 2025

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212013 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2013 - 2020
Net Product Sales Revenue
7.00B7.63B
Log In
Log In
Log In
Upgrade
Sanofi Collaboration Revenue
--
Log In
Log In
Log In
Upgrade
Other Collaboration Revenue
--
Log In
Log In
Log In
Upgrade
Total Collaboration Revenue
6.66B6.06B
Log In
Log In
Log In
Upgrade
Other Product Revenue
559.40M515.00M
Log In
Log In
Log In
Upgrade
Revenue (Other)
7.00B7.63B
Log In
Log In
Log In
Upgrade
Revenue (Total)
14.21B14.20B
Log In
Log In
Log In
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai.